Release Date: 29/01/19 08:29 Summary: Tamarama 3 Reports Initial Flow Rate of 2.5 mmcf/day Price Sensitive: Yes Download Document 823.07KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%